News

Floodgates open for unproven wellness drugs after US lifts peptide curbs

Financial Times

Telehealth and beauty groups race to cash in on booming demand for unproven anti-ageing and sexual enhancement treatments

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.